Yuan-Tsong Chen Selected Research

1,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)

2/2012	Association of the congenital neuromuscular form of glycogen storage disease type IV with a large deletion and recurrent frameshift mutation.
2/2011	Glycogen-branching enzyme deficiency leads to abnormal cardiac development: novel insights into glycogen storage disease IV.
12/2010	Glycogen storage disease type IV: novel mutations and molecular characterization of a heterogeneous disorder.
3/2008	A case of congenital glycogen storage disease type IV with a novel GBE1 mutation.
4/2006	Non-lethal congenital hypotonia due to glycogen storage disease type IV.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuan-Tsong Chen Research Topics

Disease

18	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2018 - 04/2004
10	Glycogen Storage Disease Type II (Pompe's Disease) 02/2013 - 04/2002
6	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 05/2021 - 03/2012
6	Hypersensitivity (Allergy) 09/2015 - 04/2006
6	Drug Hypersensitivity (Drug Allergy) 09/2013 - 08/2007
5	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017 - 03/2005
5	Drug-Related Side Effects and Adverse Reactions 03/2016 - 08/2005
5	Neoplasms (Cancer) 08/2014 - 01/2003
5	Glycogen Storage Disease Type IV (Andersen's Disease) 02/2012 - 04/2006
4	Glycogen Storage Disease (Glycogenosis) 08/2014 - 03/2002
3	Inflammation (Inflammations) 01/2020 - 09/2013
3	Adenoma (Adenomas) 07/2016 - 08/2014
3	Cicatrix (Scar) 09/2015 - 03/2005
3	Glycogen Storage Disease IIIA 04/2014 - 01/2007
2	Bacterial Infections (Bacterial Infection) 01/2020 - 03/2010
2	Dermatitis 01/2020 - 01/2017
2	Immune System Diseases (Immune Disorders) 01/2020 - 09/2013
2	Drug Hypersensitivity Syndrome 01/2018 - 03/2005
2	Ischemic Stroke 11/2017 - 09/2011
2	Carcinoma (Carcinomatosis) 07/2016 - 04/2015
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016 - 09/2013
2	Muscle Hypotonia (Hypotonia) 01/2014 - 02/2012
2	Amyloidosis 01/2014 - 06/2010
2	Osteoporosis 01/2014 - 06/2010
2	Alopecia (Baldness) 01/2014 - 06/2010
2	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2012 - 07/2008
2	Cardiomyopathies (Cardiomyopathy) 08/2011 - 05/2007
2	Thromboembolism 12/2009 - 10/2009
2	Hepatorenal form of glycogen storage disease 04/2008 - 10/2002
2	Hyperuricemia 03/2005 - 03/2002
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 02/2005 - 04/2002
1	Anemia 12/2019
1	Exanthema (Rash) 01/2018
1	Amyloid Plaque 01/2018
1	Achondroplasia 01/2017
1	Spondylocarpotarsal synostosis 01/2017
1	Atopic Dermatitis (Atopic Eczema) 01/2017
1	Dwarfism 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Chromosomal Instability (Chromosome Stability) 07/2016
1	Adenocarcinoma 07/2016
1	Adenomatous Polyps 07/2016
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 07/2016
1	Retinal Diseases 07/2016
1	Muscular Dystrophies (Muscular Dystrophy) 07/2016
1	Stroke (Strokes) 03/2016
1	Papillary Thyroid Cancer 03/2016
1	Pain (Aches) 03/2016
1	Skin Abnormalities 11/2015
1	Graves Disease (Basedow Disease) 07/2015
1	Agranulocytosis (Granulocytopenia) 07/2015

Drug/Important Bio-Agent (IBA)

15	Pharmaceutical PreparationsIBA 03/2016 - 04/2004
12	HLA-B Antigens (HLA-B)IBA 01/2018 - 04/2004
11	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2003
11	Carbamazepine (Tegretol)FDA LinkGeneric 01/2018 - 04/2004
7	Biomarkers (Surrogate Marker)IBA 02/2015 - 05/2003
7	EnzymesIBA 05/2007 - 04/2002
6	HLA Antigens (Human Leukocyte Antigens)IBA 07/2015 - 04/2004
6	GlycogenIBA 02/2013 - 04/2002
6	AcidsIBA 02/2013 - 04/2002
6	alpha-Glucosidases (Acid Maltase)IBA 07/2008 - 04/2002
5	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016 - 04/2006
5	human GAA protein (Myozyme)FDA Link 02/2013 - 10/2004
5	1,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)IBA 02/2012 - 04/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2007
3	Biological ProductsIBA 01/2020 - 05/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 03/2010
3	Allopurinol (Remid)FDA LinkGeneric 09/2015 - 03/2005
3	Peptides (Polypeptides)IBA 12/2011 - 03/2005
3	AmylopectinIBA 02/2011 - 03/2008
3	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 04/2008 - 03/2002
2	Immunoglobulins (Immunoglobulin)IBA 05/2021 - 01/2018
2	TransferasesIBA 01/2020 - 11/2015
2	Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)IBA 04/2014 - 01/2007
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2013 - 03/2010
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013 - 03/2012
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2012 - 12/2011
2	abacavir (Ziagen)FDA Link 07/2012 - 08/2007
2	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 06/2010 - 11/2009
2	Warfarin (Coumadin)FDA LinkGeneric 12/2009 - 10/2009
2	AnticoagulantsIBA 12/2009 - 10/2009
2	glucose tetrasaccharideIBA 08/2005 - 05/2003
2	Genetic Markers (Genetic Marker)IBA 03/2005 - 04/2004
1	continuous erythropoietin receptor activator FDA Link 12/2019
1	Long Noncoding RNAIBA 01/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018
1	Keratins (Keratin)IBA 01/2018
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2018
1	HLA-A31 antigenIBA 01/2018
1	Interleukin-33IBA 01/2017
1	Immunologic Factors (Immunomodulators)IBA 01/2017
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2017
1	FilaminsIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 07/2016
1	Aurora Kinase AIBA 07/2016
1	GlycosyltransferasesIBA 07/2016
1	protein O-mannose beta-1,2-N-acetylglucosaminyltransferaseIBA 07/2016
1	P-2 (P 2)IBA 03/2016

Therapy/Procedure

7	Therapeutics 03/2016 - 03/2002
6	Enzyme Replacement Therapy 02/2013 - 05/2003